U.S., May 22 -- ClinicalTrials.gov registry received information related to the study (NCT06982781) titled 'FRED Retrospective Study of Intracranial Aneurysms Treatment' on April 29.
Brief Summary: To evaluate the long-term safety and efficacy of Flow Re-Direction Endoluminal Device System (FRED) in the treatment of intracranial aneurysms in the post-market environment
Study Start Date: May, 2025
Study Type: OBSERVATIONAL
Condition:
Intracranial Aneurysm
Intervention:
DEVICE: Flow Re-Direction Endoluminal Device System(FRED)
Flow Diverter (FD) devices are developed based on reconstructing the parent artery's lumen. FDs are designed with a denser mesh compared to conventional intracranial stents. By covering the aneurysm neck, these ...